Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Kober

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
European Journal of Heart Failure|August 19, 2003
VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in contextEric J Velazquez, Marc A Pfeffer, John V McMurray, et al.
European Journal of Heart Failure|September 24, 2024
Sex differences in cardiac structure and function following acute myocardial infarction: Insights from the PARADISE-MI echocardiographic substudyXiaowen Wang, Maria A Pabon, Maja Cikes, et al.
JAMA|October 3, 2013
Association of national initiatives to improve cardiac arrest management with rates of bystander intervention and patient survival after out-of-hospital cardiac arrestMads Wissenberg, Freddy K Lippert, Fredrik Folke, et al.
Journal of the American College of Cardiology|May 7, 2011
Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject dataThais Coutinho, Kashish Goel, Daniel Corrêa de Sá, et al.
European Heart Journal|March 1, 2008
Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT studyEldrin F Lewis, Eric J Velazquez, Scott D Solomon, et al.
European Journal of Haematology|November 6, 2024
Risk of Cardiovascular Disease in Patients With Classical Hodgkin Lymphoma: A Danish Nationwide Register-Based Cohort StudySissel J Godtfredsen, Harman Yonis, Joachim Baech, et al.
Circulation. Heart Failure|March 12, 2021
Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan: Insights From a Combined PARAGON-HF and PARADIGM-HF AnalysisLuis E Rohde, Brian L Claggett, Emil Wolsk, et al.
Circulation|March 17, 2004
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)Douglas L Mann, John J V McMurray, Milton Packer, et al.
Circulation|June 29, 2026
AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026)Mary Norine Walsh, Lars Kober, Karen Sliwa, et al.
JACC. Heart Failure|May 11, 2020
Myocardial Infarction in Heart Failure With Preserved Ejection Fraction: Pooled Analysis of 3 Clinical TrialsJonathan W Cunningham, Muthiah Vaduganathan, Brian L Claggett, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
European Journal of Heart Failure|August 19, 2003
VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in contextEric J Velazquez, Marc A Pfeffer, John V McMurray, et al.
European Journal of Heart Failure|September 24, 2024
Sex differences in cardiac structure and function following acute myocardial infarction: Insights from the PARADISE-MI echocardiographic substudyXiaowen Wang, Maria A Pabon, Maja Cikes, et al.
JAMA|October 3, 2013
Association of national initiatives to improve cardiac arrest management with rates of bystander intervention and patient survival after out-of-hospital cardiac arrestMads Wissenberg, Freddy K Lippert, Fredrik Folke, et al.
Journal of the American College of Cardiology|May 7, 2011
Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject dataThais Coutinho, Kashish Goel, Daniel Corrêa de Sá, et al.
European Heart Journal|March 1, 2008
Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT studyEldrin F Lewis, Eric J Velazquez, Scott D Solomon, et al.
European Journal of Haematology|November 6, 2024
Risk of Cardiovascular Disease in Patients With Classical Hodgkin Lymphoma: A Danish Nationwide Register-Based Cohort StudySissel J Godtfredsen, Harman Yonis, Joachim Baech, et al.
Circulation. Heart Failure|March 12, 2021
Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan: Insights From a Combined PARAGON-HF and PARADIGM-HF AnalysisLuis E Rohde, Brian L Claggett, Emil Wolsk, et al.
Circulation|March 17, 2004
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)Douglas L Mann, John J V McMurray, Milton Packer, et al.
Circulation|June 29, 2026
AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026)Mary Norine Walsh, Lars Kober, Karen Sliwa, et al.
JACC. Heart Failure|May 11, 2020
Myocardial Infarction in Heart Failure With Preserved Ejection Fraction: Pooled Analysis of 3 Clinical TrialsJonathan W Cunningham, Muthiah Vaduganathan, Brian L Claggett, et al.
Pageof 11